Anti-obesity jabs could reduce the risk of heart attacks, strokes or heart failure in obese people regardless of the amount ...
Novo Nordisk’s weight loss injection semaglutide — the ingredient inside its wildly popular drugs Ozempic and Wegovy — could ...
Those taking the drugs for at least three years cut their risk of heart attack, stroke or cardiac death by 20 per cent ...
Ozempic could dramatically reduce the risk of heart attacks and stroke, a new study indicates. The weight loss jab has become ...
A study has found the anti-obesity drug sold under brand names Wegovy, Ozempic and Rybelsus could reduce the risk of heart attacks, strokes ...
As a major study shows it cuts heart attack risks experts say semaglutide could 'transform many chronic diseases of ageing' ...
New analyses of a large trial presented at the European Congress on Obesity showed the clear benefits of the popular ...
An obesity drug could cut heart disease and stroke risks even if you don’t lose any weight. New research has shown that ...
“Patients taking Novo Nordisk’s Wegovy obesity treatment maintained an average of 10% weight loss after four years, ...
Share on Pinterest Researchers say weight-loss medications such as Ozempic can help with heart health as well as long-term ...
The UK is one of the heaviest nations in Europe now with 63.8 per cent of the population overweight or obese, and one in four ...
Global obesity rates have nearly tripled since 1975, per WHO and Goldman Sachs. The growing usage of GLP-1 drugs in weight ...